Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

The use of anthrax as a bioweapon is rare, but devastating. This new treatment might one day save people that are beyond the ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the "point of no return" after just a ...

When exposed to lethal toxin or B. anthracis, mice with either modified MEK1/2 or MEK3/6 had much greater survival than normal animals, indicating that anthrax must inactivate both the ERK and p38 ...

We need new approaches to treat this later stage of the disease.” When B. anthracis enters the body through inhalation, ingestion, injection or contact with skin, it produces two proteins that ...

The 24 pathogen families listed in the reference tool include microorganisms that cause Covid-19 and Nipah virus, among ...